- D56.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D56.0 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D56.0 – other international versions of ICD-10 D56.0 may differ.
ICD-10-CM D56.0 is grouped within Diagnostic Related Group(s):
- 791 Prematurity with major problems
- 793 Full term neonate with major problems
- 811 Red blood cell disorders with mcc
- 812 Red blood cell disorders without mcc
Applicable To
- Alpha thalassemia major
- Hemoglobin H Constant Spring
- Hemoglobin H disease
- Hydrops fetalis due to alpha thalassemia
- Severe alpha thalassemia
- Triple gene defect alpha thalassemia
Type 1 Excludes
- alpha thalassemia trait or minor (D56.3)
- asymptomatic alpha thalassemia (D56.3)
- hydrops fetalis due to isoimmunization (P56.0)
- hydrops fetalis not due to immune hemolysis (P83.2)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D56.0:
- Bart\’s > hemoglobin or Hb D58.2
- H (Hb-H) (thalassemia) > hemoglobin or Hb D58.2
- Constant Spring > H (Hb-H) (thalassemia) D56.0
- Bart\’s disease > Hb (abnormal)
- H Constant Spring > Hemoglobin
- alpha thalassemia > due to P56.0
- alpha thalassemia > due to P56.0
- alpha (major) (severe) (triple gene defect) > Thalassemia (anemia) (disease) D56.9